Characterisation of ATRX, a chromatin remodelling protein
In plain English
AI plain-English summaryEvery cell in the human body carries the same DNA, yet a red blood cell churns out haemoglobin while a nerve cell never does—and a faulty protein that controls this switching process leaves children with severe learning difficulties, distinctive facial features, abnormal genital development, and anaemia. This condition, ATR-X syndrome, arises from mutations in a protein called ATRX, which helps package and unpack DNA to regulate which genes are active. Despite the revolution in human genome sequencing, scientists still do not understand how this packaging machinery works in detail. The project aims to determine exactly what ATRX does inside the cell and how its disruption leads to such a wide range of symptoms—likely because it perturbs the expression of many different genes. This is fundamental science. There is no immediate practical application. But understanding how a single protein can orchestrate the expression of multiple genes across different tissues could eventually point toward ways to mitigate the effects of ATR-X syndrome or other disorders where gene regulation goes awry. Similar fundamental work on chromatin remodelling has already reshaped how researchers think about cancer, development, and inherited disease.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
IntramuralPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know